1. Home
  2. HFWA vs IMTX Comparison

HFWA vs IMTX Comparison

Compare HFWA & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Financial Corporation

HFWA

Heritage Financial Corporation

HOLD

Current Price

$29.24

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

IMTX

Immatics N.V.

HOLD

Current Price

$9.73

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFWA
IMTX
Founded
1927
N/A
Country
United States
Germany
Employees
N/A
407
Industry
Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
HFWA
IMTX
Price
$29.24
$9.73
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$30.50
$19.00
AVG Volume (30 Days)
463.9K
387.7K
Earning Date
04-23-2026
05-13-2026
Dividend Yield
3.53%
N/A
EPS Growth
58.06
N/A
EPS
0.90
N/A
Revenue
N/A
N/A
Revenue This Year
$45.85
N/A
Revenue Next Year
$7.83
$25.91
P/E Ratio
$61.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.32
$5.05
52 Week High
$31.25
$12.41

Technical Indicators

Market Signals
Indicator
HFWA
IMTX
Relative Strength Index (RSI) 45.26 54.27
Support Level $28.91 $9.58
Resistance Level $29.29 $10.67
Average True Range (ATR) 0.69 0.52
MACD -0.15 0.11
Stochastic Oscillator 15.26 88.79

Price Performance

Historical Comparison
HFWA
IMTX

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company, through its subsidiary, provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as non-interest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: